A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to characterize the pharmacodynamic profile of Formoterol Fumarate and Foradil Aerolizer

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dey
• Treatments: Formoterol Fumarate

Criteria

Inclusion Criteria:

• Able to understand the requirements of the study and provide informed consent

• A Clinical diagnosis of COPD

• A current or prior history of at least 10-pack years of cigarette smoking

• women of child-bearing potential (WOCBP) must have a negative pregnancy test at the Screening Visit and agree to avoid becoming pregnant for the duration of study

Exclusion Criteria:

• A Clinical Diagnosis of Asthma

• Other significant disease than COPD

• Subjects who radiation or chemotherapy within the previous 12 months

• Subjects who had any lung resection

• QTcB greater than 0.460 seconds

• History of illegal drug abuse or alcohol abuse within the past 5 years